114 related articles for article (PubMed ID: 35734598)
1. Effectiveness and Safety of Therapeutic Vaccines for Precancerous Cervical Lesions: A Systematic Review and Meta-Analysis.
Cai S; Tan X; Miao K; Li D; Cheng S; Li P; Zeng X; Sun F
Front Oncol; 2022; 12():918331. PubMed ID: 35734598
[TBL] [Abstract][Full Text] [Related]
2. [Clinical research progress and implications of therapeutic vaccines for cervical cancer and precancerous lesions: a qualitative systematic review].
Cai S; Miao K; Tan XY; Cheng S; Li DT; Zeng XY; Yang Y; Meng RR; Liu ZK; Li Y; Li KL; Sun F; Zhan SY
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):743-760. PubMed ID: 35880341
[No Abstract] [Full Text] [Related]
3. Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports.
Jørgensen L; Gøtzsche PC; Jefferson T
Syst Rev; 2020 Feb; 9(1):43. PubMed ID: 32106879
[TBL] [Abstract][Full Text] [Related]
4. Reproductive and Lifestyle Characteristics of Kenyan Women Presenting With Precancerous Cervical Lesions: A Hospital-Based Case-Control Study.
Muitta E; Were T; Kebira AN
East Afr Health Res J; 2019; 3(2):115-124. PubMed ID: 34308204
[TBL] [Abstract][Full Text] [Related]
5. Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers.
Dehlendorff C; Baandrup L; Kjaer SK
J Natl Cancer Inst; 2021 Jul; 113(7):869-874. PubMed ID: 33377930
[TBL] [Abstract][Full Text] [Related]
6. Effect of heat-clearing and dampness-eliminating Chinese medicine for high-risk cervical cancer papillomavirus infection: a systematic review and meta-analysis of randomized controlled trials.
Huang S; Qi Y; Chen S; He B; Chen X; Xu J
Front Med (Lausanne); 2023; 10():1022030. PubMed ID: 37692777
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of high-risk human papillomavirus and cervical lesion risk factors: A population-based study in Zhejiang, China 2010-2019.
Lu W; Chen T; Yao Y; Chen P
J Med Virol; 2021 Aug; 93(8):5118-5125. PubMed ID: 33913528
[TBL] [Abstract][Full Text] [Related]
8. Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: Umbrella review of systematic reviews.
Villa A; Patton LL; Giuliano AR; Estrich CG; Pahlke SC; O'Brien KK; Lipman RD; Araujo MWB
J Am Dent Assoc; 2020 Apr; 151(4):245-254.e24. PubMed ID: 31983391
[TBL] [Abstract][Full Text] [Related]
9. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer.
Liu G; Sharma M; Tan N; Barnabas RV
AIDS; 2018 Mar; 32(6):795-808. PubMed ID: 29369827
[TBL] [Abstract][Full Text] [Related]
10. Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women.
Aro K; Nieminen P; Louvanto K; Jakobsson M; Virtanen S; Lehtinen M; Dillner J; Kalliala I
Gynecol Oncol; 2019 Aug; 154(2):354-359. PubMed ID: 31176553
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study.
Casajuana-Pérez A; Ramírez-Mena M; Ruipérez-Pacheco E; Gil-Prados I; García-Santos J; Bellón-Del Amo M; Hernández-Aguado JJ; de la Fuente-Valero J; Zapardiel I; Coronado-Martín PJ
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214747
[No Abstract] [Full Text] [Related]
13. High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.
Hidalgo-Tenorio C; de Jesus SE; Esquivias J; Pasquau J
Enferm Infecc Microbiol Clin (Engl Ed); 2018 Nov; 36(9):555-562. PubMed ID: 29208455
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy in patients with local HPV infection and high-grade squamous intraepithelial lesion following uterine cervical conization.
Kovachev SM
Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):314-318. PubMed ID: 32429720
[TBL] [Abstract][Full Text] [Related]
15. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
16. Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.
Deshmukh AA; Chiao EY; Cantor SB; Stier EA; Goldstone SE; Nyitray AG; Wilkin T; Wang X; Chhatwal J
Cancer; 2017 Dec; 123(23):4709-4719. PubMed ID: 28950043
[TBL] [Abstract][Full Text] [Related]
17. Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.
Bhuyan PK; Dallas M; Kraynyak K; Herring T; Morrow M; Boyer J; Duff S; Kim J; Weiner DB
Hum Vaccin Immunother; 2021 May; 17(5):1288-1293. PubMed ID: 33175656
[TBL] [Abstract][Full Text] [Related]
18. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
[TBL] [Abstract][Full Text] [Related]
19. Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
Polterauer S; Reich O; Widschwendter A; Hadjari L; Bogner G; Reinthaller A; Joura E; Trutnovsky G; Ciresa-Koenig A; Ganhoer-Schimboeck J; Boehm I; Berger R; Langthaler E; Aberle SW; Heinze G; Gleiss A; Grimm C
Gynecol Oncol; 2022 Apr; 165(1):23-29. PubMed ID: 35177279
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
